Does the CNP/NPR-C pathway maintain vascular homeostasis and can NPR-C agonists reduce blood pressure?
Mice with endothelial-specific deletion of Nppc (encoding C-type natriuretic peptide), wild-type mice, and mice lacking NPR-C
Endothelial-specific deletion of Nppc; administration of small-molecule NPR-C agonists
Wild-type mice; mice lacking NPR-C
Vascular regulation including endothelial dysfunction, hypertension, atherogenesis, aneurysm, vasorelaxation, and blood pressuresurrogate
The CNP/NPR-C pathway is essential for preserving vascular homeostasis, and NPR-C agonists represent a potential disease-modifying therapeutic target for cardiovascular disorders like hypertension.
The endothelium plays a fundamental role in maintaining vascular homeostasis by releasing factors that regulate local blood flow, systemic blood pressure, and the reactivity of leukocytes and platelets. Accordingly, endothelial dysfunction underpins many cardiovascular diseases, including hypertension, myocardial infarction, and stroke. Herein, we evaluated mice with endothelial-specific deletion of Nppc, which encodes C-type natriuretic peptide (CNP), and determined that this mediator is essential for multiple aspects of vascular regulation. Specifically, disruption of CNP leads to endothelial dysfunction, hypertension, atherogenesis, and aneurysm. Moreover, we identified natriuretic peptide receptor-C (NPR-C) as the cognate receptor that primarily underlies CNP-dependent vasoprotective functions and developed small-molecule NPR-C agonists to target this pathway. Administration of NPR-C agonists promotes a vasorelaxation of isolated resistance arteries and a reduction in blood pressure in wild-type animals that is diminished in mice lacking NPR-C. This work provides a mechanistic explanation for genome-wide association studies that have linked the NPR-C (Npr3) locus with hypertension by demonstrating the importance of CNP/NPR-C signaling in preserving vascular homoeostasis. Furthermore, these results suggest that the CNP/NPR-C pathway has potential as a disease-modifying therapeutic target for cardiovascular disorders.
Building similarity graph...
Analyzing shared references across papers
Loading...
Amie J. Moyes
Rayomand S. Khambata
Inmaculada Concepción Villar
Journal of Clinical Investigation
University College London
Queen Mary University of London
Universidad Autónoma de Madrid
Building similarity graph...
Analyzing shared references across papers
Loading...
Moyes et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69dcc343f729781886359637 — DOI: https://doi.org/10.1172/jci74281